Salem Investment Counselors’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
OGC
CMF
IFS
SMH
CD
NFSG
Salem Investment Counselors's ALAB Position: Q3 2026 in Review
Salem Investment Counselors reduced its Astera Labs (ALAB) stake by 14% in Q3 2026, selling an estimated $7.78M and leaving 154,723 shares worth $55.1M. The position accounts for 1.37% of the portfolio, ranked #16.
Salem Investment Counselors first reported a position in ALAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $86.4M in Q2 2026. 97 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.
- Salem Investment Counselors held 154,723 shares of Astera Labs worth $55.1M as of Q3 2026.
- Salem Investment Counselors sold 24,185 Astera Labs shares in Q3 2026, an estimated $7.78M.
- Astera Labs made up 1.37% of Salem Investment Counselors's portfolio in Q3 2026, its #16 holding.
- Salem Investment Counselors first reported a position in Astera Labs in Q2 2025 and has held it in 6 quarters since.
- Salem Investment Counselors's Astera Labs position peaked at $86.4M in Q2 2026.
- 97 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.
Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.